11 withdrawn. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Withdrawn 11 |
Follow Dermatitis, Atopic: new trials by email Literature Review of Dermatitis, Atopic trials Research Report on Dermatitis, Atopic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis Upadacitinib, Placebo for Upadacitinib - Atopic Dermatitis, Sleep Disturbance | Phase 3 | Withdrawn | AbbVie | 2024-05-23 | 2024-09-19 | |
| CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis CBP-201, Placebo - Atopic Dermatitis | Phase 3 | Withdrawn | Connect Biopharm LLC | 2022-12-01 | 2023-03-21 | |
| Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis JW-100, Eucrisa - Atopic Dermatitis | Phase 3 | Withdrawn | Applied Biology, Inc. | 2022-11-24 | 2022-12-19 | |
| A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil Upadacitinib, Placebo for Upadacitinib - Atopic Dermatitis (AD) | Phase 3 | Withdrawn | AbbVie | 2020-12-24 | 2021-04-08 | |
| Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects Product 0405, Placebo for Product 0405 - Atopic Dermatitis | Phase 3 | Withdrawn | Fougera Pharmaceuticals Inc. | 2012-06-01 | 2014-06-27 | |
| Study to Determine the Pharmacokinetics of Product 0405 Product 0405 - Atopic Dermatitis | Phase 3 | Withdrawn | Fougera Pharmaceuticals Inc. | 2012-06-01 | 2014-06-27 | |
| Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects Product 0405, Placebo for Product 0405 - Atopic Dermatitis | Phase 3 | Withdrawn | Fougera Pharmaceuticals Inc. | 2012-06-01 | 2014-06-27 | |
| Management of Eczema by Specific Probiotic Strains Ecologic ® Panda II, placebo - Eczema, Atopic Dermatitis | Phase 3 | Withdrawn | Agentschap NL | 2011-03-01 | 2016-01-12 | |
| Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis dexamethasone 0.5 mg and 1.0 mg clemastine cream, Dexamethasone 0,5 mg cream - Dermatitis | Phase 3 | Withdrawn | Azidus Brasil | 2010-11-01 | 2022-11-03 | |
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older MSRD-100, Vehicle - Atopic Dermatitis | Phase 3 | Withdrawn | Merz North America, Inc. | 2016-09-09 | ||
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older MSRD-100, Vehicle - Atopic Dermatitis | Phase 3 | Withdrawn | Merz North America, Inc. | 2016-09-09 |
Eczema (4) · Dermatitis (3) · Hypersensitivity (3) · Pruritus (3) · Exanthema (2) · Genetic Diseases, Inborn (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Genetic (2) · Parasomnias (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11) · Skin and Connective Tissue Diseases (11) · Genetic Diseases, Inborn (9) · Hypersensitivity, Immediate (9) · Immune System Diseases (9) · Skin Diseases (9) · Skin Diseases, Eczematous (9) · Skin Diseases, Genetic (9) · Dermatitis (8) · Hypersensitivity (8) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Mental Disorders (1) · Nervous System Diseases (1)
Exercise (2) · upadacitinib (2) · Dexamethasone (1) · crisaborole (1)
Fougera Pharmaceuticals Inc. (3) · AbbVie (2) · Merz North America, Inc. (2) · Agentschap NL (1) · Applied Biology, Inc. (1) · Azidus Brasil (1) · Connect Biopharm LLC (1)
Brazil (2) · Netherlands (1)
Angela C Kaplan (3) · Michael Kuligowski, MD, PhD, MBA (2) · Arine M Vlieger, MD, PhD (1) · Daniel Fonseca, MD (1) · Suzhou Connect (1)